Cargando…
Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
BACKGROUND: Ischemic stroke is a leading cause of permanent disability and death globally. The nucleotide‐biding oligomaerization domain (NOD)‐like receptor family pyrin domain‐containing 3 (NLRP3) inflammasome is a multi‐protein complex that plays a role in ischemic stroke. Recently, research on th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493663/ https://www.ncbi.nlm.nih.gov/pubmed/37088947 http://dx.doi.org/10.1111/cns.14232 |
_version_ | 1785104527035203584 |
---|---|
author | Zhu, Hua Zhang, Yonggang Feng, Shi Li, Yina Ye, Yingze Jian, Zhihong Xiong, Xiaoxing Gu, Lijuan |
author_facet | Zhu, Hua Zhang, Yonggang Feng, Shi Li, Yina Ye, Yingze Jian, Zhihong Xiong, Xiaoxing Gu, Lijuan |
author_sort | Zhu, Hua |
collection | PubMed |
description | BACKGROUND: Ischemic stroke is a leading cause of permanent disability and death globally. The nucleotide‐biding oligomaerization domain (NOD)‐like receptor family pyrin domain‐containing 3 (NLRP3) inflammasome is a multi‐protein complex that plays a role in ischemic stroke. Recently, research on the role of NLRP3 in ischemic stroke has developed rapidly worldwide. However, there is no bibliometric analysis of NLRP3 in ischemic stroke to date. AIM: Through bibliometric analysis, the aim of this study was to assess the current state of research on NLRP3 in the field of ischemic stroke research worldwide over the past 12 years and to identify important results, major research areas, and emerging trends. METHODS: Publications related to NLRP3 in ischemic stroke from January 1, 2011 to December 31, 2022 were obtained from the Web of Science Core Collection (WoSCC). We used HistCite, VOSviewer, CiteSpace, and Bibliometrix for bibliometric analysis and visualization. The Total Global Citation Score (TGCS) was employed to assess the impact of publications. RESULTS: We found that research of NLRP3 in ischemic stroke developed rapidly starting in 2011. 601 relevant studies have been published in 245 journals over the past 12 years. Journal of Neuroinflammation and International Immunopharmacology were the most productive journals and Journal of Neuroinflammation was the most cited journal. Additionally, Stroke and Journal of Cerebral Blood Flow & Metabolism were the most co‐cited journal. The most productive country was China (records = 430) and the most productive university was the Zhejiang University (records = 24). Arumugam TV (TGCS = 949) was the most cited author in this field. NLRP3 inflammasome activation, nf–κb, oxidative stress, and inflammation were the knowledge bases for the research in this field. CONCLUSION: This study is a scientometric study utilizing quantitative and qualitative methods to comprehensively review the publications on NLRP3 in ischemic stroke. This information provides a reference for scholars to further study NLRP3 in ischemic stroke. |
format | Online Article Text |
id | pubmed-10493663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104936632023-09-12 Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis Zhu, Hua Zhang, Yonggang Feng, Shi Li, Yina Ye, Yingze Jian, Zhihong Xiong, Xiaoxing Gu, Lijuan CNS Neurosci Ther Original Articles BACKGROUND: Ischemic stroke is a leading cause of permanent disability and death globally. The nucleotide‐biding oligomaerization domain (NOD)‐like receptor family pyrin domain‐containing 3 (NLRP3) inflammasome is a multi‐protein complex that plays a role in ischemic stroke. Recently, research on the role of NLRP3 in ischemic stroke has developed rapidly worldwide. However, there is no bibliometric analysis of NLRP3 in ischemic stroke to date. AIM: Through bibliometric analysis, the aim of this study was to assess the current state of research on NLRP3 in the field of ischemic stroke research worldwide over the past 12 years and to identify important results, major research areas, and emerging trends. METHODS: Publications related to NLRP3 in ischemic stroke from January 1, 2011 to December 31, 2022 were obtained from the Web of Science Core Collection (WoSCC). We used HistCite, VOSviewer, CiteSpace, and Bibliometrix for bibliometric analysis and visualization. The Total Global Citation Score (TGCS) was employed to assess the impact of publications. RESULTS: We found that research of NLRP3 in ischemic stroke developed rapidly starting in 2011. 601 relevant studies have been published in 245 journals over the past 12 years. Journal of Neuroinflammation and International Immunopharmacology were the most productive journals and Journal of Neuroinflammation was the most cited journal. Additionally, Stroke and Journal of Cerebral Blood Flow & Metabolism were the most co‐cited journal. The most productive country was China (records = 430) and the most productive university was the Zhejiang University (records = 24). Arumugam TV (TGCS = 949) was the most cited author in this field. NLRP3 inflammasome activation, nf–κb, oxidative stress, and inflammation were the knowledge bases for the research in this field. CONCLUSION: This study is a scientometric study utilizing quantitative and qualitative methods to comprehensively review the publications on NLRP3 in ischemic stroke. This information provides a reference for scholars to further study NLRP3 in ischemic stroke. John Wiley and Sons Inc. 2023-04-23 /pmc/articles/PMC10493663/ /pubmed/37088947 http://dx.doi.org/10.1111/cns.14232 Text en © 2023 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Zhu, Hua Zhang, Yonggang Feng, Shi Li, Yina Ye, Yingze Jian, Zhihong Xiong, Xiaoxing Gu, Lijuan Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis |
title | Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis |
title_full | Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis |
title_fullStr | Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis |
title_full_unstemmed | Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis |
title_short | Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis |
title_sort | trends in nlrp3 inflammasome research in ischemic stroke from 2011 to 2022: a bibliometric analysis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493663/ https://www.ncbi.nlm.nih.gov/pubmed/37088947 http://dx.doi.org/10.1111/cns.14232 |
work_keys_str_mv | AT zhuhua trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis AT zhangyonggang trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis AT fengshi trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis AT liyina trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis AT yeyingze trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis AT jianzhihong trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis AT xiongxiaoxing trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis AT gulijuan trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis |